Skip to main content

H2O America Receives Regulatory Approval for Texas Subsidiary’s Acquisition of Quadvest

Transactions Expected to Close October 1, 2026 SAN JOSE, Calif. and MAGNOLIA, Texas, Aug. 17, 2026 (GLOBE NEWSWIRE) — H2O America (NASDAQ: HTO) today announced that its regulated Texas water and wastewater utility, The Texas Water Company, Inc. (“TWC”), along with its affiliate Texas Water Operation Services, LLC (“TWOS”), and Quadvest, a regulated investor-owned water and wastewater utility operating in the Houston metro area, have received the state and federal regulatory approvals needed to complete their respective agreements pursuant to which TWC and TWOS will acquire all of the assets owned by Quadvest. The transactions are expected to close on October 1, 2026. Upon closing, the combination will significantly expand H2O America’s presence in Texas and advance its strategy to diversify and strengthen its regulated utility operations...

Continue reading

Chief Media Acquires AMZ Advisers and Reach Social, Expanding Access to Amazon and TikTok Shop Retail Platforms

Independent agency expands commerce capabilities across Amazon, TikTok Shop and global ecommerce markets NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) — Chief Media, an independent performance media and data science agency, today announced that it has acquired AMZ Advisers, an ecommerce and digital marketing consultancy, and, with it, AMZ Advisers’ stake in Reach Social, a creator-led social commerce agency. The acquisitions expand Chief Media’s commerce capabilities across Amazon, TikTok Shop and other fast-growing marketplaces, providing brands with a more connected approach to paid media, marketplace strategy and social commerce as purchasing decisions increasingly move across platforms. By acquiring the two agencies, Chief Media gains additional technology and expertise to help clients access Amazon and TikTok Shop ecommerce opportunities...

Continue reading

In National Advertising Division Challenge, Quanovate Tech Voluntarily Discontinues Mira Fertility Monitor and Test Wand Claims

Following a BBB National Programs’ National Advertising Division challenge brought by The Procter & Gamble Company (P&G), Quanovate Tech, Inc. voluntarily discontinued claims for its Mira Fertility Monitor and Test Wands. New York, NY, Aug. 17, 2026 (GLOBE NEWSWIRE) — Following a BBB National Programs’ National Advertising Division challenge brought by The Procter & Gamble Company (P&G), Quanovate Tech, Inc. voluntarily discontinued claims for its Mira Fertility Monitor and Test Wands.  P&G and Quanovate sell competing fertility monitors and wands. P&G challenged Quanovate’s comparative, performance, and superiority claims for its Mira Fertility Monitor and Test Wands.   During the inquiry, Quanovate voluntarily agreed to permanently discontinue all of the challenged claims. NAD did not review the claims...

Continue reading

Baosheng Pursues Strategic Acquisition of Blue Intelligence Cloud Innovation Technology to Accelerate Its Expansion into AI Marketing

BEIJING, Aug. 17, 2026 (GLOBE NEWSWIRE) — Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng” or the “Company”) today announced that it has entered into a strategic acquisition memorandum of understanding with Blue Intelligence Cloud Innovation Technology (Beijing) Co., Ltd. (“Blue Intelligence Cloud Innovation Technology”). Under the proposed transaction, Baosheng intends to acquire a 40% equity interest in Blue Intelligence Cloud Innovation Technology. If successfully completed, the strategic investment is expected to provide Baosheng with access to robust AI-powered capabilities, including AI intelligent marketing, intelligent content generation, user data analytics, and AI-enabled operations. The two parties plan to establish synergies around AI-driven traffic acquisition, user insights, precision engagement, marketing...

Continue reading

Volaris Group Announces the Acquisition of Alertacall, UK-based Provider of Tenant Engagement Technology for Social Housing

TORONTO, Aug. 17, 2026 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Alertacall, a UK-based provider of customer engagement and communications technology for the social housing and retirement living sectors. Alertacall delivers a purpose-built combination of Software as a Service (SaaS) software, dedicated hardware, and a UK-based contact center, enabling housing providers to meet their regulatory obligations and improve contact with older and vulnerable customers. “After more than 21 years of growing Alertacall – which started with my invention of the ‘I’m okay button’ for my grandmother Eveline – we are all incredibly proud to have built something that delivers such an amazing impact for so many people,” said Alertacall founder and CEO James Batchelor MBE. “But with such huge opportunities...

Continue reading

Schouw & Co. share buy-back programme, week 33 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 7 August 2026 242,183 646.46 156,560,665    Monday,...

Continue reading

Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

Combined company to operate as Slate Medicines and focus on advancing Slate’s portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class subcutaneous anti-PACAP/VIP monoclonal antibody for the preventative treatment of migraine Concurrent oversubscribed private placement financing of $245 million from a leading syndicate of healthcare investors anticipated to fund operations into 2029 Companies to hold conference call on August 17, 2026, at 8:00 a.m. ET CAMBRIDGE, Mass. and RALEIGH, N.C., Aug. 17, 2026 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC) and Slate Medicines, Inc. (“Slate”), a biotechnology company developing next-generation therapeutics for the treatment of migraine, announced today that they have entered...

Continue reading

A.P. Moller Capital agrees to acquire a majority stake in leading Moroccan logistics company Globex Investissement

A.P. Moller Capital – Emerging Markets Infrastructure Fund II and APM Capital Morocco Fund to acquire majority stake in Globex, establishing a partnership with Founder and CEO Omar El Kadiri, who will remain in place along with an experienced management team Strong alignment with A.P. Moller Capital’s geographic and sector focus in Morocco and in transportation and logistics Globex is underpinned by exclusive local market licensing agreements, with established market positions in express delivery, road freight, freight forwarding and customs brokerageCOPENHAGEN, Denmark and CASABLANCA, Morocco, Aug. 17, 2026 (GLOBE NEWSWIRE) — A.P. Moller Capital is pleased to announce that A.P. Moller Capital – Emerging Markets Infrastructure Fund II (“EMIF II”) and APM Capital Morocco Fund (together “the Funds”) have signed an agreement...

Continue reading

Diana Shipping Inc. Withdraws Offer to Acquire Genco Shipping & Trading Following Genco Board’s Outrageous Demands

Following Nine Months of Avoiding Engagement, Genco Board Demands Consideration Valued at Approximately $36.91 Per Share — a 57% Premium to Genco’s Undisturbed Share Price at the Time of Diana’s Last Offer Genco’s Demands Are Completely Disconnected from the Reality of What a Credible Buyer Could Reasonably Be Expected to Pay Shareholders Should Question Whose Interests Their Board Is Actually Serving By Making Demands That Can’t Possibly Be Met, Shareholders are Effectively Being Prevented from Realizing an Attractive Premium, As Board Makes its Misalignment with Shareholders and Primary Focus on its Personal Interests Crystal Clear Diana Remains Genco’s Largest Shareholder and Will Continue to Raise These Issues and Hold the Board Accountable for Every Commitment It Has Made. ATHENS, Greece, Aug. 14, 2026 (GLOBE NEWSWIRE) —...

Continue reading

Strata Biotech Labs, LLC Earns NSF/ANSI 455-2 Dietary Supplement GMP Certification

Independent certification from global human health organization NSF demonstrates a commitment to personal care product quality and compliance with U.S. GMP requirementsDr Christina Rahm / Strata Biotech LabDr. Christina Rahm, Founder of Strata Biotech Labs, at the company’s NSF/ANSI 455-2 GMP-certified manufacturing facility in Las Vegas, Nevada.Las Vegas, Nevada, Aug. 14, 2026 (GLOBE NEWSWIRE) — Strata Biotech Labs, LLC’s manufacturing facility in Las Vegas, Nevada, was recently added to NSF’s NSF/ANSI 455-2 Dietary Supplements Good Manufacturing Practice (GMP) certification. Earning GMP certification from NSF verifies that a manufacturing facility has the proper methods, equipment, facilities and controls in place to produce dietary supplement products. Strata Biotech Labs’ facility at 6320 McLeod Drive, Suite 1, Las...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.